NeuBase Therapeutics to Present at the Stifel 2020 Virtual Healthcare Conference on Tuesday, November 17

Rhea-AI Summary

NeuBase Therapeutics (NASDAQ: NBSE) announced that CEO Dietrich A. Stephan, Ph.D., will present a corporate overview at the Stifel 2020 Virtual Healthcare Conference from November 16-18. The presentation is scheduled for November 17 at 8:40 a.m. ET. Attendees can join via the provided webcast link or on the company's website. NeuBase is focused on advancing genetic medicine through its proprietary PATrOL™ therapies to address genetic diseases at their source.

PITTSBURGH, Nov. 10, 2020 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (NASDAQ: NBSE) (“NeuBase” or the “Company”), a biotechnology company accelerating the genetic revolution using a new class of synthetic medicines, announced today that Dietrich A. Stephan, Ph.D., Chief Executive Officer of NeuBase, will present a corporate overview at the Stifel 2020 Virtual Healthcare Conference being held on November 16 - 18.

Stifel 2020 Virtual Healthcare Conference
Date:	Tuesday, November 17TH
Time:	8:40 a.m. ET
Location:	Webcast Link - or at the company’s website (click here)

About NeuBase Therapeutics
NeuBase is accelerating the genetic revolution using a new class of synthetic medicines. NeuBase’s designer PATrOL™ therapies are centered around its proprietary drug scaffold to address genetic diseases at the source by combining the highly targeted approach of traditional genetic therapies with the broad organ distribution capabilities of small molecules. With an initial focus on silencing disease-causing mutations in debilitating neurological, neuromuscular and oncologic disorders, NeuBase is committed to redefining medicine for the millions of patients with both common and rare conditions. To learn more, visit www.neubasetherapeutics.com.

NeuBase Investor Contact:
Dan Ferry
Managing Director
LifeSci Advisors, LLC
Daniel@lifesciadvisors.com
OP: (617) 430-7576

NeuBase Media Contact:
Cait Williamson, Ph.D.
LifeSci Public Relations
cait@lifescipublicrelations.com
OP: (646) 751-4366

FAQ

When will NeuBase Therapeutics present at the Stifel 2020 Virtual Healthcare Conference?

NeuBase Therapeutics will present on November 17, 2020, at 8:40 a.m. ET.

Where can I watch the NeuBase presentation at the Stifel conference?

The presentation can be watched via the webcast link or on NeuBase's website.

What is the focus of NeuBase Therapeutics’ research?

NeuBase Therapeutics focuses on using synthetic medicines to treat genetic diseases, particularly through its PATrOL™ therapies.

What is the significance of the Stifel 2020 Virtual Healthcare Conference for NBSE?

The conference provides NeuBase an opportunity to showcase its advancements in genetic medicine and connect with investors.